Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1493 of 5804
-
Stroke drug combo shows promise in clearing tiny clots
Disease control CompletedThe functional prognosis of patients with ischaemic stroke treated by thrombolysis and thrombectomy is associated with complete reperfusion of the occluded artery defined by an mTICI 2C or 3 score at the end of thrombectomy. However, this complete reperfusion is only obtained in …
Phase: PHASE2 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study is a prospective, single-arm, open-label phase II study to evaluate the efficacy and safety of the combination of Utidelone and bevacizumab regimen in patients with ≥ 2 lines of HER-2 negative advanced breast cancer.
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Video game magic: AR adventure cuts opioid need in young cancer patients
Symptom relief CompletedTo learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients scheduled for surgery.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Pitolisant shows promise for Long-Term control of idiopathic hypersomnia
Disease control CompletedThe primary objective of this study is to assess the long-term safety and effectiveness of pitolisant in patients with idiopathic hypersomnia (IH) who completed the Double-Blind Randomized Withdrawal Phase of study HBS-101-CL-010.
Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Cochlear implants could help those deaf in one ear hear better in noise
Disease control Recruiting nowThe aim of the study is to assess the continued efficacy and safety of cochlear implantation in participants aged 5 years and above with Unilateral Hearing Loss (UHL)/Single Sided Deafness (SSD) supporting a change indication for use.
Phase: NA • Sponsor: Cochlear • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
New study tests better breathing support for critically ill patients
Disease control CompletedThe aim of this study is to elaborate on the effectiveness of recruitment maneuver by airway pressure release ventilation (APRV) as an open lung ventilatory strategy in comparison with PRVC mode in lung protective strategy regarding improvement of LUS score and P/F ratio in patie…
Phase: NA • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New antibody therapy targets blood cancers in early trial
Disease control OngoingThe purpose of this study is to characterize safety and to determine the putative recommended Phase 2 dose(s) (RP2D\[s\]), optimal dosing schedule(s) and route(s) of administration of JNJ-80948543 in Part A (Dose Escalation) and to further characterize the safety of JNJ-80948543 …
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New antibody combo shows promise in early cancer trial
Disease control CompletedThis study is to evaluate the safety and tolerability of JAB-BX102 monotherapy and combination therapy with pembrolizumab in adult participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo shows promise in early trial
Disease control CompletedSL03-OHD-105 is an open-label, multicenter, phase 1b trial designed to evaluate SL-172154 administered in combination with pegylated liposomal doxorubicin (PLD) or mirvetuximab soravtansine (MIRV) in patients with platinum resistant ovarian cancer. Approximately 102 patients will…
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New stroke drug shows promise in early trial
Disease control CompletedThis is a phase II, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy of multiple doses of LT3001 drug product in subjects with acute ischemic stroke (AIS)
Phase: PHASE2 • Sponsor: Lumosa Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Sleep program aims to reduce pregnancy risks in african american women
Disease control Recruiting nowThe purpose of this randomized controlled trial is to establish the effectiveness of a culturally targeted and individually tailored behavioral intervention to promote maternal glucose metabolism in African American women.
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New MRI scan could replace needle test for liver patients
Diagnosis Recruiting nowHow to construct a novel, non-invasive, accurate, and convenient method to achieve prediction of hepatic venous pressure gradient (HVPG) is an important general problem in the management of portal hypertension in cirrhosis or advanced chronic liver disease. We plan to investigate…
Sponsor: Shengjing Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
Kidney alert team may cut deaths in hospital patients
Disease control CompletedKidney disease in its chronic or acute form shares many risk factors for initiation, progression and prognosis with an increase in morbidity and mortality, the length of hospitalization and the cost associated with stages of increasing severity. Its overall estimated prevalence i…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a nurse or an app fix sleep after brain injury?
Symptom relief Recruiting nownsomnia is a frequent complaint reported by patients with TBI, and exacerbates their ability to return to productive activity, which subsequently elevate related healthcare costs and burden. Existing literatures found that effects of CBTi, first-line therapy for insomnia, on post…
Phase: NA • Sponsor: Taipei Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New combo aims to extend control of tough pancreatic cancer
Disease control OngoingThis study is a Phase 1b/2, dose-escalation, randomized, multicenter study to assess the efficacy, safety, tolerability, and PK of ivaltinostat in combination with capecitabine and capecitabine monotherapy in patients with metastatic pancreatic adenocarcinoma whose disease has no…
Phase: PHASE1, PHASE2 • Sponsor: CG Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New inhaler may ease mouth pain for head and neck cancer patients
Symptom relief Recruiting nowRadiation therapy is the main treatment for nasopharyngeal carcinoma (NPC), and standard care for advanced NPC often includes combination chemotherapy and radiation (CCRT). However, many patients experience serious side effects, such as painful mouth sores (Radiation-Induced Oral…
Phase: PHASE3 • Sponsor: Affiliated Hospital of Guangdong Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Blood test could revolutionize throat cancer monitoring
Knowledge-focused Recruiting nowCancers of the throat, oropharyngeal squamous cell carcinoma (OPSCC), are highly prevalent across Scotland. Over the past 10 years, both global and Scottish cases of OPSCC have increased, particularly those associated with human papillomavirus (HPV). However there has been little…
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Church health coaches aim to lower blood pressure in rural alabama
Prevention OngoingThe goal of this study is to test an intervention to prevent high blood pressure among rural, Black adults living in Alabama. Black adults in this region have one of the highest rates of high blood pressure in the US. Eating fruits and vegetables and exercising daily lowers the c…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Mindfulness, a smart ring, and a pod: a new bundle aims to shield healthcare workers from burnout
Symptom relief CompletedMind-body resilience is particularly important in workplaces where there are frequent exposures to primary or secondary emotional and/or physical trauma. A 2020 report from the U.S. Bureau of Labor Statistics highlighted health workers as among the largest service industries in t…
Phase: NA • Sponsor: Ohio State University • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC
-
New Dual-Target antibody enters human trials for advanced cancers
Disease control Recruiting nowThis is a Phase I study designed to evaluate if experimental anti-PD-1 and anti-TIM-3 bispecific antibody, LB1410, is safe, tolerable and efficacious in participants with advanced solid tumors or lymphoma.
Phase: PHASE1 • Sponsor: L & L Bio Co., Ltd., Ningbo, China • Aim: Disease control
Last updated Jun 26, 2026 15:48 UTC